Phreesia, Inc. submitted a Form 144 filing with the Securities and Exchange Commission, indicating that certain shareholders are planning to sell their shares in the company. While the filing itself does not necessarily mean that the sales will occur, it provides transparency to investors about the potential for increased market supply. Investors often monitor Form 144 filings as they can impact the stock price if significant amounts of shares are sold.
Phreesia, Inc. is a healthcare technology company that provides software solutions to healthcare providers, with a focus on improving the patient experience. Their platform allows patients to check-in digitally, complete medical forms, verify insurance, and make payments. The company aims to streamline administrative processes for healthcare providers and enhance patient engagement. For more information about Phreesia, Inc., visit their website here.
Form 144 is filed with the SEC by holders of restricted securities who intend to sell those securities in the open market. It is required to be filed if the proposed sale exceeds 5,000 shares or $50,000 in any three-month period. The filing provides details about the securities being sold, the relationship of the seller to the company, and the method of sale. It is important for investors to track Form 144 filings to stay informed about potential changes in market supply and demand for a company’s stock.
Read More:
Phreesia, Inc. (0001412408) Submits Form 144 Filing: What You Need to Know
Leave a Reply